Sinonasal Therapies and Histologic Correlations of Patients With Cystic Fibrosis in the Era of Highly Effective Modulator Therapy

Part of paid clinical trials in Indianapolis, Indiana.

Sponsor
Indiana University
Study ID
NCT06996951
Phase
PHASE3
Status
Recruiting

Conditions

  • Chronic Rhinosinusitis (CRS)
  • Cystic Fibrosis (CF)

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • STOP NASAL SALINE IRRIGATION WITH OR WITHOUT STEROID — OTHER
    PATIENT WILL STOP USING NASAL SALINE IRRIGATION WITH OR WITHOUT STEROID
  • CONTINUE NASAL SALINE IRRIGATION WITH OR WITHOUT STEROID — DRUG
    PATIENT WILL CONTINUE USING NASAL SALINE IRRIGATION WITH OR WITHOUT STEROID

Study Details

The investigators are doing this study to discover if it is appropriate for people with Cystic Fibrosis (CF) on highly effective modulator therapy (HEMT) to stop using certain standard Sino nasal therapies such as high-volume nasal saline irrigations, topical nasal steroids, and topical nasal antibiotics. They are also going to study the fluid inside the nose to see if there are changes when stopping these therapies. Right now, they are not sure if it is suggested to stop these treatments when patients begin highly effective modulator therapy (HEMT)

Key Dates

Start date
Jul 2, 2025
Status verified
Dec 2025
Primary completion
Jul 31, 2026
Completion
Jul 31, 2026

Study Design

Enrollment
64 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: CONTINUE TOPICAL STEROID NASAL IRRIGATION
    PARTICIPANTS WILL CONTINUE THEIR NASAL TREATMENT WHICH WAS ALREADY PRESCRIBED BY THEIR PHYSICIAN
  • Experimental: STOP TOPICAL NASAL TREATMENT
    PARTICIPANTS IN THIS ARM WILL BE ASKED TO STOP THEIR NASAL TREATMENT

Primary Outcome Measure

Change in Lund Kennedy Score [ Time Frame: Baseline, 12 weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Indiana University HealthIndianapolisIndiana46202
Elisa A Illing
317-944-6467
Azeezat A Yekinni
317-529-6883
Elisa A Illing (PRINCIPAL_INVESTIGATOR)

Find similar trials in Indianapolis, IN

Related Studies